ASSESSMENT OF THE QUALITY OF LIFE OF CHILDREN AFTER PARATHYROIDECTOMY WITH PRIMARY HYPERPARATHYROIDSIS ACCORDING TO THE PAS TABLE (PARATHYROID ASSESSMENT OF SYMPTOMS SCORE) AND SF-36 QUESTIONNAIRE

Khodjaeva F.S.; Nasirova K.K.; Rikhsiyeva N.T.; Mukhammedaminova D.T.

doi:10.5281/zenodo.11403665

ASSESSMENT OF THE QUALITY OF LIFE OF CHILDREN AFTER PARATHYROIDECTOMY WITH PRIMARY HYPERPARATHYROIDSIS ACCORDING TO THE PAS TABLE (PARATHYROID ASSESSMENT OF SYMPTOMS SCORE) AND SF-36 QUESTIONNAIRE

31.05.2024 International Scientific Journal "Science and Innovation". Series D. Volume 3 Issue 5

Khodjaeva F.S., Nasirova K.K., Rikhsiyeva N.T., Mukhammedaminova D.T.

Abstract. The article presents literature data on the frequency and structure of the causes of primary hyperparathyroidism. It is known that PHPT manifests itself in a multisymptomatic clinical picture, involving various organs and systems in the pathological process, which leads to a significant decrease in the quality of life, disability of patients, and an increased risk of premature death. This article highlights the value of the PAS chart and SF-36 questionnaire not only in terms of assessing long-term results of surgery, but also in terms of diagnosing early stages of PHPT.

Keywords: primary hyperparathyroidism; parathyroidectomy; table PAS; SF-36 questionnaire.

References:

1. Ismailov S.I., Khodzhamberdieva D.Sh., Rikhsieva N.T. Osteoporosis and low-energy femoral neck fractures as a complication of various endocrine diseases (literature review) //International Endocrinological Journal. – 2013. – No. 5 (53). – pp. 113-120. 2. Mokrysheva N.G., Rozhinskaya L.Ya., Peretokina E.V. and others. Analysis of the main epidemiological characteristics of primary hyperparathyroidism in Russia (according to the register) // Problems of endocrinology. - 2012. - T. 58. - No. 5. - P. 16-20. . doi: 10.14341/probl201258516-20 3. “Osteoporosis and low-energy fractures of the femoral neck as a complication of various endocrine diseases” Ismailov S.I., Khojamberdieva D.Sh., Rikhsieva N.T. International Endocrinological Journal” Ukraine, Donetsk highway, 5 (53) 2013, pp. 113 – 120. Rikhsieva N.T. Evaluation of the effectiveness of parathyroidectomy for primary hyperparathyroidism using the PAS table. // Journal of Biomedicine and Practice. - 2020.-No. 4. - P. 336-341. (14.00.00; №24) 4. Rikhsieva N. T. Primary hyperparathyroidism: etiology, pathogenesis, clinical picture, diagnosis, treatment, quality of life (literature review) // International Endocrinological Journal. – 2014. – No. 1 (57). – pp. 103-108. 5. Rikhsieva N. T., Khodzhaeva F. S., Toshpulatova G. T. MECHANISMS OF DEVELOPMENT OF HYPERPARATHYROIDSIS IN CHILDREN //Medicus. – 2016. – No. 2. – pp. 130-131. 6. Khodzhaeva F. S., Rikhsieva N. T., Son T. R. ASPECTS OF THYROID CANCER //Medicus. – 2017. – No. 2. – pp. 80-81. 7. Khodzhaeva F. S., Rikhsieva N. T., Arifdzhanova Zh. F. DIAGNOSTIC EVALUATION OF PRIMARY HYPERPARATHYROIDSIS //Medicus. – 2016. – No. 2. – pp. 132-133. Kuznetsov N.S., Kim I.V., Kuznetsov 8. S.N. Intraoperative determination of parathyroid hormone in the strategy of surgical treatment of primary hyperparathyroidism // Endocrine surgery. - 2011. - T. 5. - No. 2. - P. 18-25. . doi: 10.14341/2306-3513-2011-2-18-25 9. Rozhinskaya L.Ya., Rostomyan L.G., Tyulpakov A.N. Pituitary adenomas and multiple neoplasia syndrome type 1. In the book: Clinical neuroendocrinology / Ed. Dedova I.I. - M.: UP Print. 2011. . 10. Rikhsieva N.T., Rikhsiev R.SH. Results of surgical treatment of primary hyperparathyroidism in children. //American Journal of Medicine and Medical Sciences. - 2023, 13(3):249-258. DOI: 10.5923/j.ajmms.20231303.13 (14.00.00; No. 2) 11. Rikhsieva N.T., Results of a retrospective analysis of primary hyperparathyroidism in children. //The American Journal of Medical Sciences and Pharmaceutical Research.-2023.-Vol.05.-Issue Pages:37-58; https://doi.org/10.37547/TAJMSPR. (14.00.00; (35) SJIF= 6.319) 12. Rikhsieva N.T., Ismailov S.I. Comparative analysis of the quality of life of children with primary hyperparathyroidosis during the long periods after parathyroidectomy. // Chin J Ind Hyg Occup Dis.- 2021.-Vol.39. No.13.PP 464-470 (14.00.00; No. 25) 13. Nazira Rikhsieva. The effectiveness of parathyroidectomy in children with primary hyperparathyroidism. Endocrine Abstracts. 19th European Congress Endocrinology 2017. 20 –23 May 2017, Lisbon, Portugal 14. Chiavistelli S, Bilezikian JP. Does calcium intake influence the development of primary hyperparathyroidism? IBMS Bonekey. 2013;10. doi: 10.1038/bonekey.2013.48 15. Sharretts JM, Kebebew E, Simonds WF. Parathyroid cancer. Seminars in Oncology. 2010;37(6):580–90 16. Rosen CJ, Bouillon R, Compston JE, Rosen V. Primer on the metabolic bone diseases and disorders of mineral metabolism. Wiley. 2013 17. Witteveen JE, van Thiel S, Romijn JA, Hamdy NA. Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol. 2013;168(3):R45-R53. doi: 10.1530/EJE-12-0528 18. Bollerslev J, Rejnmark L, Marcocci C, et al. European society of endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol. 2015;173(2):G1-G20. doi: 10.1530/EJE-15-0628 19. Schwarz P, Body JJ, Cap J, et al. The PRIMARA study: a prospective, descriptive, observational study to review cinacalcet use in patients with primary hyperparathyroidism in clinical practice. Eur J Endocrinol. 2014;171(6):727-735. doi: 10.1530/EJE-14-0355 20. Cavalier E, Plebani M, Delanaye P, Souberbielle JC. Considerations in parathyroid hormone testing. Clin Chem Lab Med. 2015;53(12):1913-1919. doi: 10.1515/cclm-2015-0314 21. Sidhu PS, Talat N, Patel P, Mulholland NJ, Schulte KM. Ultrasound features of malignancy in the preoperative diagnosis of parathyroid cancer: a retrospective analysis of parathyroid tumors larger than 15 mm. Eur Radiol 2011;21:1865–73 22. Yeh MW, Ituarte PHG, Zhou HC, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocr Metab. 2013;98(3):1122-1129. doi: 10.1210/jc.2012-4022 23. Ilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3561-3569. doi: 10.1210/jc.2014-1413 24. Hu MI, Glezerman I, Leboulleux S, et al. Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment. J Natl Cancer Inst. 2013;105(18):1417-1420. doi: 10.1093/jnci/djt225 25. Boikos SA, Hammers HJ. Denosumab for the treatment of bisphosphonate-refractory hypercalcemia. J Clin Oncol. 2012;30(29):e299. doi: 10.1200/JCO.2012.41.7923 26. Karuppiah D, Thanabalasingham G, Shine B, Wang LM, Sadler GP, Karavitaki N, et al. Refractory hypercalcaemia secondary to parathyroid carcinoma: response to high-dose denosumab. Eur J Endocrinol 2014;171:K1–5 27. Rikhsieva N.T. Long-term results of parathyroidectomy in children with primary hyperparathyroidism. //Eurasian Bulletin of Pediatrics.-2021.- No. 3.- P. 59-65 (14.00.00; (30.08.2019 year 268/7. Decision № 3. )